Clinical Trial Update: Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and tolerability of PRO-229 ophthalmic solution versus Lagricel Ofteno PF for Dry Eye Disease and Ocular Surface Di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Ocular Surface Disease

Drugs mentioned

• Lagricel Ofteno PF
• PRO-229 Ophthalmic Solution

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Disease, Ocular Surface Disease | Phase 1 | Status: COMPLETED